Navigation Links
Siemens Medical Solutions Receives CCHIT Certification for Soarian Clinicals With Siemens Pharmacy and Med Administration Check
Date:11/5/2007

t on the quality and safety of patient care," said Mark Leavitt, M.D., Ph.D., chair of the Commission. "I'd like to congratulate the first round of certified product companies, who now represent the leading edge in advanced EHR products for the inpatient setting."

Siemens offers many solutions that assist healthcare organizations in establishing closed-loop medication management processes that support improvements to the safety, timeliness, and effectiveness of ordering, dispensing, and administering medications, thereby reducing the risk of medication errors and adverse events. The solution of Soarian Clinicals V2.0C5 with Siemens Pharmacy and Med Administration Check V24.0 provides a workflow-engineered healthcare information system that enables physicians and other care givers to capture and manage their orders; the pharmacists to ensure accuracy and efficiency when drugs are dispensed; and nurses to verify the right patient, right time and frequency, right dosage, right route of administration and right medication at the point of administration. Additionally, Soarian provides the tools needed to support evidence-based decision making and its powerful workflow engine allows alerts, triggers and rules to be set by the healthcare providers, prompting care givers to take immediate action as soon as there is a gap or breakdown in the planned care delivery process . helping to ensure the highest quality of patient care delivery.

The CCHIT Certified mark - a "seal of approval" for EHR products - provides the first consensus-based, government-recognized benchmark for inpatient EHR products. By looking to products with the CCHIT Certified seal, acute care providers can reduce their risk in selecting EHR products for CPOE and eMAR.

"Being one of the first inpatient vendors to have a CCHIT certified product clearly demonstrates our ongoing commitment to support our customers by meeting the changing industry requirements. Siemens also is and always will be
'/>"/>

SOURCE Siemens Medical Solutions
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4

Related medicine news :

1. Siemens Extends Tender Offer for Acquisition of Dade Behring
2. Siemens Congratulates Kenneth R. Bertka, M.D., Recipient of 2007 AMDIS Award
3. Siemens Announces Early Termination of Hart-Scott-Rodino Waiting Period For Acquisition of Dade Behring Holdings, Inc.; U.S. Antitrust Clearance Achieved
4. MEDRAD Announces eCoil(TM) for Siemens, Philips 3.0T MR Scanners
5. VIDEO from Medialink and Siemens: The Next Generation Allergy Test - Nothing to Sneeze At
6. Siemens Building Technologies Pioneers Wireless Solution for St. Anthonys Sensitive Environment
7. Susquehanna Health and Siemens Announce Plans to Improve Hospital Facilities Through Technology Investment
8. Siemens Medical Solutions Diagnostics Announces the Release of the Rapidlab 1200 Series Version 2.0 Software
9. VIDEO from Medialink and Siemens: Worlds Smallest Ultrasound Package Launches in the U.S.
10. Siemens Soarian Health Information Management is Widely Adopted by Leading Healthcare Institutions in 2007
11. James Cracknell Launches Siemens Stroke for Stroke Week
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2008)...ifficult to treat the malignancy, experts explain ...omen who have had their breasts augmented with imp...ast cancer may be treated successfully with a part...apy, according to an Arizona physician and researc...hese augmented women," said Dr. Robert Kuske Jr., ...
(Date:12/1/2008)...next time you visit a dentist,in the mid-Michigan... pressure,in addition to your brushing habits. ,...edical Center/McLaren Health,Care and the Michiga...t,project designed to have dentists and physician...ood pressure in patients. , "Dentists are t...
(Date:12/1/2008)...ire/ -- As part of the Dec. 1 observance of Worl...mes today urged Pennsylvanians to be tested for HI...d ongoing efforts to educate the public about the ...essage is clear: regardless of your personal backg...V is the only sure way to know your status and to ...
(Date:12/1/2008)...ive alternative to conventional angiography for ev...nary artery disease; true even if the patients hav...a study performed at the Thomas Jefferson Universi...ded 31 patients who had one or more calcified coro...ronary CTA. Calcified plaques in the arteries were...
Breaking Medicine News(10 mins):Health News:Radioactive 'Seed' Rx Helps Women With Implants Fight Breast Cancer 2Health News:Radioactive 'Seed' Rx Helps Women With Implants Fight Breast Cancer 3Health News:Dental and Medical Communities Piloting Partnership in Mid-Michigan To Detect and Defeat Disease 2Health News:Dental and Medical Communities Piloting Partnership in Mid-Michigan To Detect and Defeat Disease 3Health News:PA Department of Health Recognizes 20th Anniversary of World AIDS Day; Urges HIV Testing 2
...nglo-American company has been allowed to store wh...ure by the US Food and Drug Administration. White... system that defend the body against both infectio...materials. The company will reportedly take 480-mi...
...nvironmental group Friday welcomed the European Un...ade which causes environmental pollution, and urge...ink and other green groups hailed the EU resolutio...oup had called upon governments across the world t...
...United States and other northern mid- and upper-la...tting global warming than previously thought , acc...f Science. The study, which sheds light on the so-...s that intact tropical forests are removing an une...
...man Jim Carreys lady love Jenny McCarthy has revea...er . The actress insisted that the couple will be ...Beach beach beach beach beach. We like to sit and .... Stare at the ocean and go 'ohhmmm, People quoted...
Other Medicine News:Health News:Northern Forests Less Effective Than Tropical Forests in Reducing Global Warming 2Health News:Northern Forests Less Effective Than Tropical Forests in Reducing Global Warming 3
(Date:11/25/2008)...ov. 25 Poniard,Pharmace...al company focused on,innovative oncology therapi...ategic alternatives for its preclinical research p...s resources on the clinical development of picopla...he initial commercialization of,picoplatin in the...
(Date:11/25/2008)...-FirstCall/ -- CardioVascular,BioTherapeutics, In...t it has,dosed the first patient in North America...l to treat patients with severe coronary heart dis...f CORonary heart Disease) trial will include,four...s in approximately 120,patients with severe coron...
(Date:11/24/2008)...ewswire-FirstCall/ -- Leaders of Schering-Plough C... for investors on the company,s research pipeline,... includes 46 new entities in clinical trials or un...s. , , "Research and development is adding ...inue our transformation," said Fred Hassan, chairm...
(Date:11/24/2008)... Unveils Rich Development Pipeline of Compounds Me...H, N.J., Nov. 24 Scherin... top-line results of a long-term Phase III clinica...M) (asenapine) demonstrating efficacy and safety i...ial, asenapine was statistically significantly mor...
Breaking Medicine Technology:Poniard Pharmaceuticals Announces Management Changes and Focus on Development and Commercialization of Picoplatin 2Poniard Pharmaceuticals Announces Management Changes and Focus on Development and Commercialization of Picoplatin 3CVBT Doses First Patient in its Phase II Clinical Trial for Severe Coronary Heart Disease 2CVBT Doses First Patient in its Phase II Clinical Trial for Severe Coronary Heart Disease 3Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects 2Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects 3Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects 4Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects 5Schering-Plough Unveils Top-Line Study Results for SAPHRIS(TM) (asenapine) Demonstrating Efficacy in Long-Term Schizophrenia Relapse Prevention 2Schering-Plough Unveils Top-Line Study Results for SAPHRIS(TM) (asenapine) Demonstrating Efficacy in Long-Term Schizophrenia Relapse Prevention 3Type 1 diabetes triggered by lazy regulatory T cells 3A McGill researchers 1903 1Type 1 diabetes triggered by lazy regulatory T cells 3A McGill researchers 1903 2Prominent Health Care Executive Kevin Kraushaar Joins Triadvocates LLC as Managing Principal of DC Office 9562 1Prominent Health Care Executive Kevin Kraushaar Joins Triadvocates LLC as Managing Principal of DC Office 9562 2Prominent Health Care Executive Kevin Kraushaar Joins Triadvocates LLC as Managing Principal of DC Office 9562 3Virginia Cares Uninsured Program 28VCUP 29 Announces Early Successes in Helping Uninsured Virginians Access Quality Healthcare 9559 1Virginia Cares Uninsured Program 28VCUP 29 Announces Early Successes in Helping Uninsured Virginians Access Quality Healthcare 9559 2Virginia Cares Uninsured Program 28VCUP 29 Announces Early Successes in Helping Uninsured Virginians Access Quality Healthcare 9559 3Health Options Inc s BlueMedicare HMO Earns NCQA Excellent Rating 9556 1Health Options Inc s BlueMedicare HMO Earns NCQA Excellent Rating 9556 2
...l Approach to Address Growing Problem of Antibioti...NCOUVER, British Columbia, March 26, 2007 /PRNewsw...idate IDR-1 is the first,immune system trigger to ...on, according to a paper published in the April 20...ch highlights the work of Inimex and its,co-founde...
...NCETON, N.J., March 25, 2007 /PRNewswire/ -- Once-...dication tolvaptan, a,vasopressin receptor antagon... symptoms of acutely decompensated heart failure (...nal care, without an,adverse effect on their long-...om the short- and long-term analyses of the,intern...
Other Medicine Technology:Inimex Product Candidate is First Immune Defense Regulator to Cure,Infections Without Causing Harmful Inflammation 2Everest Data on Short- and Long-Term Use of Otsuka's,Investigational Novel Treatment, Tolvaptan, Published in Journal of,the American Medical Association and Featured in ACC's Late,Breaking Clinical Trials 2Everest Data on Short- and Long-Term Use of Otsuka's,Investigational Novel Treatment, Tolvaptan, Published in Journal of,the American Medical Association and Featured in ACC's Late,Breaking Clinical Trials 3Everest Data on Short- and Long-Term Use of Otsuka's,Investigational Novel Treatment, Tolvaptan, Published in Journal of,the American Medical Association and Featured in ACC's Late,Breaking Clinical Trials 4Everest Data on Short- and Long-Term Use of Otsuka's,Investigational Novel Treatment, Tolvaptan, Published in Journal of,the American Medical Association and Featured in ACC's Late,Breaking Clinical Trials 5Everest Data on Short- and Long-Term Use of Otsuka's,Investigational Novel Treatment, Tolvaptan, Published in Journal of,the American Medical Association and Featured in ACC's Late,Breaking Clinical Trials 6Everest Data on Short- and Long-Term Use of Otsuka's,Investigational Novel Treatment, Tolvaptan, Published in Journal of,the American Medical Association and Featured in ACC's Late,Breaking Clinical Trials 7
... is a national reference laboratory and a worldwid...elopment. ARUP offers an extensive test menu of hi...and anatomic pathology. Owned by the University of...n half of the nation's university teaching hospita...
... is a national reference laboratory and a worldwid...elopment. ARUP offers an extensive test menu of hi...and anatomic pathology. Owned by the University of...n half of the nation's university teaching hospita...
... is a national reference laboratory and a worldwid...elopment. ARUP offers an extensive test menu of hi...and anatomic pathology. Owned by the University of...n half of the nation's university teaching hospita...
... is a national reference laboratory and a worldwid...elopment. ARUP offers an extensive test menu of hi...and anatomic pathology. Owned by the University of...n half of the nation's university teaching hospita...
Medicine Products: